Evidence map›Paper›PMID 40799829›Full record

ReviewFrontiers in pharmacology2025

Exploring traditional mongolian materia medica: the path of progress from tradition to modernity.

Ruyu Shi, Enironggui Wang, Mengyang Wang, Chunhong Zhang, Tsend-Ayush Damda, Minhui Li

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruyu ShiInstitute of Chinese Materia Medica, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot, China.
Enironggui WangCollege of Pharmacy, Inner Mongolia Minzu University, Tongliao, China.
Mengyang WangInstitute of Chinese Materia Medica, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot, China.
Chunhong ZhangInstitute of Chinese Materia Medica, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot, China.
Tsend-Ayush DamdaCollege of Pharmacy, Mongolian National University of Medical Sciences (MNUMS), Ulaanbaatar, Mongolia.
Minhui LiInstitute of Chinese Materia Medica, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Mongolian medicine boasts a long history with its integrated and unigue theoretical system. Traditional Mongolian materia medica (TMMM), as the primary substance for the treatments in traditional Mongolian medicine, was thought to be an important source for drug discovery. Although interest in TMMM has recently grown among researchers, challenges of TMMM revitalisation should be concerned: (1) inheritors and sustainability, (2) effective composition and pharmacology, and (3) preparation and standardization. The purpose of the review is to introduce the current development of Mongolian medicine and summarize the future challenges to make better use of Mongolian medicine.

Indexed as

challengeschemical compositionmongolian materia medicapharmacologyresources

Identifiers

PMID40799829
PMCPMC12339552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.